CSIMarket Company Name, Ticker, Industry, else..
 
Biotech Acquisition Company  (NASDAQ: BIOT)
    Sector • Financial    Industry • Blank Checks
   Industry • Blank Checks
   Sector • Financial
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 23
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 17
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Biotech Acquisition Company is a specialized investment firm that focuses on acquiring and funding biotechnology companies. It aims to identify and support promising biotech startups or established firms with potential for growth and innovation in the field. By providing financial resources, expertise, and strategic guidance, the company plays an active role in the development and commercialization of groundbreaking biotech products and therapies. Its goal is to create value for its shareholders by investing in businesses that have the potential to revolutionize healthcare and improve patients' lives.


   Company Address: 545 West 25th Street New York 10001 NY
   Company Phone Number: 227-1905   Stock Exchange / Ticker: NASDAQ BIOT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Announcement

Pioneering the Future Instinct Brothers Announces Public Merger to Accelerate Regenerative Medicine Frontier

Published Sat, Jun 14 2025 7:16 PM UTC

NEW YORK, NY, TOKYO, JAPAN March 4, 2025 In a groundbreaking move that signals a new era for regenerative medicine, Instinct Brothers Co., Ltd., a Japanese leader in vertically integrated stem cell technologies, announced its decision to go public through a merger with Relativity Acquisition Corp., a special purpose acquisition company (SPAC). This strategic merger promi...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0
Working Capital Ratio 0.03
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0.03 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 0 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 6.05 %
Return On Investment (TTM) 7.64 %
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.